Descriptive Analysis of Reports of Drug Reaction with Eosinophilia and Systemic Symptoms from EudraVigilance and from the RegiSCAR Project
Dermatology · 19.06.2026 · 1-19
DOI: 10.1159/000552416 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatology, online erschienen am 19.06.2026. Verfasst von Diana Dubrall und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, University of Bonn, Bonn, Germany, diana.dubrall@bfarm.de. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Introduction
Drug reaction with eosinophilia and systemic symptoms (DRESS) is a T-cell-mediated severe cutaneous adverse reaction (SCAR) to drugs. Due to its rarity, there are currently only a few studies which include a larger number of cases. We sought to analyze a larger number of DRESS cases to increase knowledge of clinical symptoms, causative agents, and potentially associated factors.
Methods
This is a non-interventional, retrospective, pharmacoepidemiological study analyzing descriptively DRESS reports in the EudraVigilance ADR database (EV) and DRESS cases in the registry of dZh/RegiSCAR. The two databases were analyzed separately, and the results were compared thereafter to identify both similarities and differences.
Results
48 cases from EV and 84 RegiSCAR cases were included for the in-depth analysis. The liver was the most frequently involved inner organ. Most of the reactions occurred within 6 weeks after initiating the suspected inducing agent. The percentage of cases with fatal outcome was similar in both datasets (EV: 4.2%, RegiSCAR: 3.6%). Antiseizure drugs – especially carbamazepine – were most frequently involved in both datasets. In 4 reports from EV and 5 cases from RegiSCAR, sulfasalazine was identified as causative agent. Remarkably, all patients with sulfasalazine-induced DRESS were females with arthritic disease who were clearly younger compared to patients of the whole dataset.
Conclusion
Our study confirms results obtained from other studies regarding the frequent involvement of the liver, the time to onset, and DRESS-inducing drugs. Further studies are needed to investigate whether younger female with arthritic disease may carry a higher risk to develop DRESS or whether other factors might be responsible for this observation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, University of Bonn, Bonn, Germany, diana.dubrall@bfarm.de.
- Research Division, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany, diana.dubrall@bfarm.de.
- Dokumentationszentrum schwerer Hautreaktionen (dZh), Department of Dermatology, Medical Center - University of Freiburg, Freiburg, Germany.
- Pharmacovigilance Division, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.
- Clinical Trials Section, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.
- Institute for Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, University of Bonn, Bonn, Germany.
Zitieren
APA
Dubrall, D., Paulmann, M., Fischer-Barth, W., Bate, J., Schmid, M., Sachs, B., & Mockenhaupt, M. (2026). Descriptive Analysis of Reports of Drug Reaction with Eosinophilia and Systemic Symptoms from EudraVigilance and from the RegiSCAR Project. Dermatology, 1-19. https://doi.org/10.1159/000552416
Vancouver
Dubrall D, Paulmann M, Fischer-Barth W, Bate J, Schmid M, Sachs B, et al. Descriptive Analysis of Reports of Drug Reaction with Eosinophilia and Systemic Symptoms from EudraVigilance and from the RegiSCAR Project. Dermatology. 2026:1-19. doi:10.1159/000552416
BibTeX
@article{Dubrall2026,
author = {Dubrall, Diana and Paulmann, Maren and Fischer-Barth, Wilma and Bate, Jens and Schmid, Matthias and Sachs, Bernhardt and Mockenhaupt, Maja},
title = {Descriptive Analysis of Reports of Drug Reaction with Eosinophilia and Systemic Symptoms from EudraVigilance and from the RegiSCAR Project},
journal = {Dermatology},
year = {2026},
pages = {1--19},
doi = {10.1159/000552416}
}
EUVIMED